Leukotriene bronchoconstriction induced by allergen and exercise

American Journal of Respiratory and Critical Care Medicine

Volumn 161, Issue 2 II, 2000, Pages

  O'Byrne, P M ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

2 CYCLOPENTYL 2 [4 (2 QUINOLINYLMETHOXY)PHENYL]ACETIC ACID; 3 [3 TERT BUTYLTHIO 1 (4 CHLOROBENZYL) 5 (2 QUINOLINYLMETHOXY) 2 INDOLYL] 2,2 DIMETHYLPROPIONIC ACID; 3 [3 TERT BUTYLTHIO 1 (4 CHLOROBENZYL) 5 ISOPROPYL 2 INDOLYL] 2,2 DIMETHYLPROPIONIC ACID; ALLERGEN; CINALUKAST; LEUKOTRIENE; LEUKOTRIENE C4; LEUKOTRIENE D4; LEUKOTRIENE E4; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MONTELUKAST; PEPTIDOLEUKOTRIENE; PRANLUKAST; UNCLASSIFIED DRUG; VERLUKAST; ZAFIRLUKAST;

ALLERGIC REACTION; BRONCHOSPASM; BRONCHUS HYPERREACTIVITY; CONTROLLED STUDY; DOSE RESPONSE; EXERCISE; EXERCISE INDUCED ASTHMA; FORCED EXPIRATORY VOLUME; HUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0034095173     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.161.supplement_1.ltta-14     Document Type: Review

References (53)

1. Cockcroft, D. W., D. N. Killian, J. J. Mellon, and F. E. Hargreave. 1977. Bronchial reactivity to inhaled histamine: a method and clinical survey. Clin. Allergy 7:235-243.
2. Juniper, E. F., P. A. Frith, and F. E. Hargreave. 1981. Airway responsiveness to histamine and methacholine: relationship to minimum treatment to control symptoms of asthma. Thorax 36:575-579.
3. Adelroth, E., M. M. Morris, F. E. Hargreave, and P. M. O'Byrne. 1986. Airway responsiveness to leukotrienes C4 and D4 and to methacholine in patients with asthma and normal controls. N. Engl. J. Med. 315: 480-484.
4. Beasley, R. C., R. L. Featherstone, M. K. Church, P. Rafferty, J. G. Varby, A. Harris, C. Robinson, and S. T. Holgate. 1989. Effect of a thromboxane receptor antagonist on PGD2-and allergen-induced bronchoconstriction. J. Appl. Physiol. 66:1685-1693.
5. Thomson, N. C., R. Roberts, J. Bandouvakis, H. Newball, and F. E. Hargreave. 1981. Comparison of bronchial responses to prostaglandin F2 alpha and methacholine. J. Allergy Clin. Immunol. 68:392-398.
6. Anderson, S. D. 1985. State of the art: exercise-induced asthma. Am. Rev. Respir. Dis. 87S:191-195.
7. O'Byrne, P. M., G. Ryan, M. Morris, D. McCormack, N. L. Jones, J. L. Morse, and F. E. Hargreave. 1982. Asthma induced by cold air and its relation to nonspecific bronchial responsiveness to methacholine. Am. Rev. Respir. Dis. 125:281-285.
8. Anderson, S. D., R. E. Schoeffel, and M. Finney. 1983 Evaluation of ultrasonically nebulised solutions for provocation testing in patients with asthma. Thorax 38:284-291.
9. O'Byrne, P. M., J. Dolovich, and F. E. Hargreave. 1987. Late asthmatic responses. Am. Rev. Respir. Dis. 136:740-751.
10. de Monchy, J. G., H. F. Kauffman, P. Venge, G. H. Koeter, H. M. Jansen, H. J. Sluiter, and K. De Vries. 1985. Bronchoalveolar cosinophilia during allergen-induced late asthmatic reactions. Am. Rev. Respir. Dis. 131:373-376.
11. Cartier, A., N. C. Thomson, P. A. Frith, R. Roberts, and F. E. Hargreave. 1982. Allergen-induced increase in bronchial responsiveness to histamine: relationship to the late asthmatic response and change in airway caliber. J. Allergy Clin. Immunol. 70:170-177.
12. Cockcroft, D. W., R. E. Ruffin, J. Dolovich, and F. E. Hargreave. 1977. Allergen-induced increase in non-allergic bronchial reactivity. Clin. Allergy. 7:503-513.
13. Chan-Yeung, M., and S. Lam. 1986. Occupational asthma. Am. Rev. Respir. Dis. 133:686-703.
14. Anderton, R. C., M. T. Cuff, P. A. Frith, D. W. Cockroft, J. L. Morse, N. L. Jones, and F. E. Hargreave. 1979. Bronchial responsiveness to inhaled histamine and exercise. J. Allergy Clin. Immunol. 63:315-320.
15. Gelb, A. F., D. P. Tashkin, J. D. Epstein, H. Gong, Jr., and N. Zamel. 1985. Exercise-induced bronchodilation in asthma. Chest 87:196-201.
16. McFadden, E. R., Jr., and R. H. Ingram, Jr. 1979. Exercise-induced asthma: observations on the initiating stimulus. N. Engl. J. Med. 301:763-769.
17. McNeill, R. S., J. R. Nairn, J. S. Millar, and C. G. Ingram. 1966. Exercise-induced asthma. Q. J. Med. 137:55-67.
18. Edmunds, A. T., M. Tooley, and S. Godfrey. 1978. The refractory period after exercise-induced asthma: its duration and relation to the severity of exercise. Am. Rev. Respir. Dis. 117:247-254.
19. Taylor, I. K., R. Wellings, G. W. Taylor, and R. W. Fuller. 1992. Urinary leukotriene E4 excretion in exercise induced bronchoconstriction. J. Appl. Physiol. 145:743-748.
20. Kikawa, Y., T. Miyanomac, Y. Inoue, M. Saito, A. Nakai, Y. Shigeniatsu, S. Hosoi, and M. Sudo. 1992. Urinary leukotriene E4 after exercise challenge in children with asthma. J Allergy Clin. Immunol. 89:1111-1119.
21. Manning, P. J., R. M. Watson, D. J. Margolskee, V. C. Williams, J. I. Schwartz, and P. M. O'Byrne. 1990. Inhibition of exercise-induced bronchoconstriction by MK-571, a potent leukotriene D4-receptor antagonist. N. Engl. J. Med. 323:1736-1739.
22. Finnerty, J. P., R. Wood-Baker, H. Thomson, and S. T. Holgate. 1992. Role of leukotrienes in exercise-induced asthma: inhibitory effect of ICI 204219, a potent leukotriene D4 receptor antagonist. Am. Rev. Respir. Dis. 145:746-749.
23. Makker, H. K., L. C. Lau, H. W. Thomson, S. M. Binks, and S. T. Holgate. 1993. The protective effect of inhaled leukotriene D4 receptor antagonist ICI 204,219 against exercise-induced asthma. Am. Rev. Respir. Dis. 147:1413-1418.
24. Leff, J. A., W. W. Busse, D. S. Pearlman, E. A. Bronsky, J. Kemp, L. Hendeles, R. Dockhorn, S. Kundu, J. Zhang, B. C. Seidenberg, and T. F. Reiss. 1998. Montelukast, a leukotriene-receptor antagonist, for the treatment of mild asthma and exercise-induced bronchoconstriction. N. Engl. J. Med. 339:147-152.
25. Adelroth, E., M. D. Inman, E. Summers, D. Pace, M. Modi, and P. M. O'Byrne. 1997. Prolonged protection against exercise-induced bronchoconstriction by the leukotriene D4-receptor antagonist cinalukast. J. Allergy Clin. Immunol. 99:210-215.
26. Manning, P. J., G. L. Jones, and P. M. O'Byrne. 1987. Tachyphylaxis to inhaled histamine in asthmatic subjects. J. Appl. Physiol. 63:1572-1577.
27. Manning, P. J., C. G. Lane, and P. M. O'Byrne. 1989. The effect of oral prostaglandin E1 on airway responsiveness in asthmatic subjects. Pulm. Pharmacol. 2:121-124.
28. Henriksen, J. M., and A. Wenzel. 1984. Effect of an intranasally administered corticosteroid (budesonide) on nasal obstruction, mouth breathing, and asthma. Am. Rev. Respir. Dis. 130:1014-1018.
29. Leikauf, G. D., I. F. Ueki, J. A. Nadel, and J. H. Widdicombe. 1985. Bradykinin stimulates C1 secretion and prostaglandin E2 release by canine tracheal epithelium. Am. J. Physiol. 248:F48-F55.
30. Manning, P. M., G. L. Jones, C. G. Lane, and P. M. O'Byrne. 1988. Hislamine-induced prostaglandin E2 release from canine tracheal smooth muscle is inhibited by H2-receptor blockade (abstract). Am. Rev. Respir. Dis. 137:A373.
31. Barnes, P. J., and M. J. Brown. 1981. Venous plasma histamine in exercise-and hyperventilation-induced asthma in man. Clin. Sci. 61:159-162.
32. O'Byrne, P. M., E. H. Walters, H. Aizawa, L. M. Fabbri, M. J. Holtzman, and J. A. Nadel. 1984. Indomethacin inhibits the airway hyperresponsiveness but not the neutrophil influx induced by ozone in dogs. Am. Rev. Respir. Dis. 130:220-224.
33. Margolskee, D. J., B. G. Bigby, and H. A. Boushey. 1988. Indomethacin blocks airway tolerance to repetitive exercise but not to eucapnic hyperpnea in asthmatic subjects. Am. Rev. Respir. Dis. 137:842-846.
34. Manning, P. J., R. Watson, and P. M. O'Byrne. 1992. The effects of H2-receptor antagonists on exercise refractoriness in asthma. J. Allergy Clin. Immunol. 90:125-126.
35. Manning, P. J., R. M. Watson, and P. M. O'Byrne. 1993. Exercise-induced refractoriness in asthmatic subjects involves leukotriene and prostaglandin interdependent mechanisms. Am. Rev. Respir. Dis. 148: 950-954.
36. 2 on exercise-induced bronchoconstriction in asthmatis subjects. Am. J. Respir. Crit. Care Med. 149: 1138-1141.
37. Durham, S. R., C. F. Craddock, W. O. Cookson, and M. K. Benson. 1988. Increases in airway responsiveness to histamine precede allergen-induced late asthmatic responses. J. Allergy Clin. Immunol. 82:764-770.
38. Choudry, N. B., R. Watson, F. E. Hargreave, and P. M. O'Byrne. 1993. Time course of inflammatory cells in sputum after allergen inhalation in asthmatic subjects. J. Allergy Clin. Immunol. 91:64A.
39. Brocklehurst, W. E. 1960. The release of histamine and formation of a slow reacting substance (SRS-A) during anaphylactic shock. J. Physiol. 151:416-435.
40. Samuelsson, B. 1983. Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation. Science 220:568-575.
41. Manning, P. J., J. Rokach, J. L. Malo, D. Ethier, A. Cartier, Y. Girard, S. Charleson, and P. M. O'Byrne. 1990. Urinary leukotriene E4 levels during early and late asthmatic responses. J. Allergy Clin. Immunol. 86:211-220.
42. Taylor, G. W., I. Taylor, P. Black, N. H. Maltby, N. Turner, R. W. Fuller, and C. T. Dollery. 1989. Urinary leukotriene E4 after antigen challenge and in acute asthma and allergic rhinitis. Lancet i:584-588.
43. Taylor, I. K., K. M. O'Shaughnessy, R. W. Fuller, and C. T. Dollery. 1991. Effect of a cysteinylleukotriene receptor antagonist, ICI 204-219, on allergen-induced bronchoconstriction and airway hyperactivity in atopic subjects. Lancet 337:690-694.
44. Hamilton, A. L., R. M. Watson, G. Wyile, and P. M. O'Byrne. 1997. A 5-lipoxygenase activating protein antagonist, Bay 1005, attenuates both early and late phase allergen-induced bronchoconstriction in asthmatic subjects. Thorax 52:348-354.
45. Diamant, Z., M. C. Timmers, H. van der Veen, B. S. Friedman, M. De Smet, M. Depre, D. Hilliard, E. H. Bel, and P. J. Sterk. 1995. The effect of MK-0591, a novel 5-lipoxygenase activating protein inhibitor, on leukotriene biosynthesis and allergen-induced airway responses in asthmatic subjects in vivo. J. Allergy Clin. Immunol. 95:42-51.
46. Friedman, B. S., E. H. Bel, A. Buntinx, W. Tanaka, Y. H. Han, S. Shingo, R. Spector, and P. Sterk. 1993. Oral leukotriene inhibitor (MK-886) blocks allergen-induced airway responses. Am. Rev. Respir. Dis. 147: 839-844.
47. Higgins, D. A., and P. M. O'Byrne. 1987. Inhaled leukotriene D4 does not cause a late response in atopic subjects. Allergy Clin. Immunol. 79:141.
48. Roquet, A., B. Dahlen, M. Kumlin, E. Ihre, G. Anstren, S. Binks, and S. E. Dahlen. 1997. Combined antagonist of leukotrienes and histamine produces predominent inhibition of allergen-induced early and late phase airway obstruction in asthmatics. Am. Respir. Crit. Care Med. 155:1856-1863.
49. Hamilton, A., I. Faiferman, P. Stober, R. M. Watson, and P. M. O'Byrne. 1998. Pranlukast, a cysteinyl leukotriene receptor antagonist, attenuates allergen-induced early and late phase bronchoconstriction and airway hyperresponsiveness in asthamatic subjects. J. Allergy Clin. Immunol. 102:177-183.
50. Inman, M. D., A. L. Hamilton, H. A. Kerstjens, R. M. Watson, and P. M. O'Byrne. 1998. The utility of methacholine airway responsiveness measurements in evaluating anti-asthma drugs. J. Allergy Clin. Immunol. 101:342-348.
51. Laitinen, L. A., A. Laitinen, T. Haahtela, V. Vikka, B. W. Spur, and T. H. Lee. 1993. Leukotriene E4 and granulocytic infiltration into asthmatics airways. Lancet 341:989-990.
52. Calhoun, W. J., B. J. Lavins, M. C. Minkwitz, R. Evans, G. J. Gleich, and J. Cohn. 1998. Effect of zafirlukast (Accolate) on cellular mediators of inflammation: bronchoalveolar lavage fluid findings after segmental allergen challenge. Am. J. Respir. Crit. Care Med. 157:1381-1389.
53. Diamant, Z., J. T. Hiltermann, E. L. J. van Rensen, P. M. Callenbach, M. Veselic-Charvat, H. van der Veen, J. K. Sont, and P. J. Sterk. 1997. The effect of inhaled leukotriene D4 and methacholine on sputum cell differentials in asthma. Am. J. Respir. Crit. Care Med. 155:1247-1253.